Hydrogen
- Generic Name
- Hydrogen
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- H2
- CAS Number
- 1333-74-0
- Unique Ingredient Identifier
- 7YNJ3PO35Z
- Background
Hydrogen is under investigation in clinical trial NCT02830854 (Molecular Hydrogen for Cognitive Function and Performance in Elderly).
- Associated Conditions
- -
- Associated Therapies
- -
Hydrogen's Feasibility and Safety as a Therapy in ECPR
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-10-10
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- Boston Children's Hospital
- Target Recruit Count
- 53
- Registration Number
- NCT05574296
- Locations
- 🇺🇸
Boston Children's Hospital, Boston, Massachusetts, United States
To Evaluate the Safety of Treating Rheumatologic and Metabolic Patients With Molecular Hydrogen Supplement.
- First Posted Date
- 2022-01-19
- Last Posted Date
- 2022-02-10
- Lead Sponsor
- HoHo Biotech
- Target Recruit Count
- 30
- Registration Number
- NCT05196295
- Locations
- 🇨🇳
Min-Sheng Gereral hospital, Taoyuan, Taiwan
To Evaluate the Safety of Treating Autoimmune Diseases With Molecular Hydrogen Supplement
- First Posted Date
- 2021-11-10
- Last Posted Date
- 2021-11-10
- Lead Sponsor
- HoHo Biotech
- Target Recruit Count
- 27
- Registration Number
- NCT05116215
- Locations
- 🇨🇳
Tri-Service General Hospital, Taipei, Taiwan
Effect H2 Water on QoL of Patients Receiving Radiotherapy for High Grade Gliomas.
Phase 2
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2019-11-25
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- Stony Brook University
- Target Recruit Count
- 15
- Registration Number
- NCT04175301
- Locations
- 🇺🇸
Stony Brook University Medical Center, Stony Brook, New York, United States
Safety of Inhaled Hydrogen Gas Mixtures in Healthy Volunteers
- First Posted Date
- 2019-08-06
- Last Posted Date
- 2021-05-06
- Lead Sponsor
- Boston Children's Hospital
- Target Recruit Count
- 8
- Registration Number
- NCT04046211
- Locations
- 🇺🇸
Boston Children's Hospital, Boston, Massachusetts, United States
Clinical Trial to Evaluate the Safety and Tolerability of Hydrogen in Patients With Parkinson's Disease
- First Posted Date
- 2019-06-03
- Last Posted Date
- 2023-04-12
- Lead Sponsor
- Stony Brook University
- Target Recruit Count
- 2
- Registration Number
- NCT03971617
- Locations
- 🇺🇸
Stony Brook University Medical Center, Stony Brook, New York, United States
Neuroprotection in Acute Ischemic Stroke
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-10-24
- Last Posted Date
- 2023-12-19
- Lead Sponsor
- Stony Brook University
- Target Recruit Count
- 15
- Registration Number
- NCT03320018
- Locations
- 🇺🇸
Stony Brook University Hospital, Stony Brook, New York, United States
Therapeutic Effects of Hydrogen on Steroid-refractory/or Steroid-dependent cGVHD
- First Posted Date
- 2016-09-28
- Last Posted Date
- 2020-07-21
- Lead Sponsor
- Navy General Hospital, Beijing
- Target Recruit Count
- 21
- Registration Number
- NCT02918188
- Locations
- 🇨🇳
Navy General Hospital, Beijing, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath